BSE Live
Apr 17, 16:01Prev. Close
85.50
Open Price
85.47
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 17, 16:08Prev. Close
85.57
Open Price
85.47
Bid Price (Qty.)
91.13 (580)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of IOL Chemicals and Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
| Per Share Ratios | |||||
| Basic EPS (Rs.) | 3.44 | 22.90 | 23.70 | 28.56 | |
| Diluted EPS (Rs.) | 3.44 | 22.90 | 23.70 | 28.56 | |
| Cash EPS (Rs.) | 5.90 | 33.61 | 31.56 | 35.93 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 57.49 | 274.49 | 256.81 | 237.15 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 57.49 | 274.49 | 256.81 | 237.15 | |
| Revenue from Operations/Share (Rs.) | 70.83 | 363.28 | 377.64 | 372.00 | |
| PBDIT/Share (Rs.) | 7.65 | 44.40 | 42.80 | 49.45 | |
| PBIT/Share (Rs.) | 5.20 | 33.68 | 34.94 | 42.08 | |
| PBT/Share (Rs.) | 4.70 | 30.94 | 32.13 | 38.30 | |
| Net Profit/Share (Rs.) | 3.44 | 22.90 | 23.70 | 28.56 | |
| NP After MI And SOA / Share (Rs.) | 3.44 | 22.90 | 23.70 | 28.56 | |
| Profitability Ratios | |||||
| PBDIT Margin (%) | 10.80 | 12.22 | 11.33 | 13.29 | |
| PBIT Margin (%) | 7.34 | 9.27 | 9.25 | 11.31 | |
| PBT Margin (%) | 6.63 | 8.51 | 8.50 | 10.29 | |
| Net Profit Margin (%) | 4.86 | 6.30 | 6.27 | 7.67 | |
| NP After MI And SOA Margin (%) | 4.86 | 6.30 | 6.27 | 7.67 | |
| Return on Networth/Equity (%) | 5.98 | 8.34 | 9.22 | 12.04 | |
| Return on Capital Employed (%) | 8.61 | 11.74 | 13.09 | 17.05 | |
| Return on Assets (%) | 4.24 | 5.98 | 6.88 | 8.54 | |
| Total Debt/Equity (X) | 0.07 | 0.00 | 0.05 | 0.03 | |
| Asset Turnover Ratio (%) | 0.90 | 1.00 | 1.11 | 0.00 | |
| Liquidity Ratios | |||||
| Current Ratio (X) | 1.89 | 2.00 | 2.02 | 2.11 | |
| Quick Ratio (X) | 1.30 | 1.24 | 1.30 | 1.31 | |
| Inventory Turnover Ratio (X) | 5.29 | 3.82 | 4.18 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 23.23 | 21.83 | 16.88 | 21.00 | |
| Dividend Payout Ratio (CP) (%) | 13.56 | 14.87 | 12.68 | 16.69 | |
| Earnings Retention Ratio (%) | 76.77 | 78.17 | 83.12 | 79.00 | |
| Cash Earnings Retention Ratio (%) | 86.44 | 85.13 | 87.32 | 83.31 | |
| Coverage Ratios | |||||
| Interest Coverage Ratios (%) | 15.22 | 16.19 | 15.26 | 35.02 | |
| Interest Coverage Ratios (Post Tax) (%) | 15.22 | 16.19 | 15.26 | 35.02 | |
| Valuation Ratios | |||||
| Enterprise Value (Cr.) | 1,705.42 | 1,979.48 | 1,718.71 | 1,979.92 | |
| EV/Net Operating Revenue (X) | 0.82 | 0.93 | 0.78 | 0.91 | |
| EV/EBITDA (X) | 7.59 | 7.59 | 6.84 | 6.82 | |
| MarketCap/Net Operating Revenue (X) | 0.86 | 1.00 | 0.75 | 0.95 | |
| Retention Ratios (%) | 76.76 | 78.16 | 83.11 | 78.99 | |
| Price/BV (X) | 1.06 | 1.32 | 1.10 | 1.49 | |
| Price/Net Operating Revenue | 0.86 | 1.00 | 0.75 | 0.95 | |
| Earnings Yield | 0.06 | 0.06 | 0.08 | 0.08 |
25.02.2026
IOL Chemicals Consolidated December 2025 Net Sales at Rs 580.39 crore, up 10.91% Y-o-Y
25.02.2026
IOL Chemicals Standalone December 2025 Net Sales at Rs 580.39 crore, up 10.91% Y-o-Y
08.12.2025
17.11.2025
IOL Chemicals Consolidated September 2025 Net Sales at Rs 567.53 crore, up 7.95% Y-o-Y
25.02.2026
IOL Chemicals Consolidated December 2025 Net Sales at Rs 580.39 crore, up 10.91% Y-o-Y
25.02.2026
IOL Chemicals Standalone December 2025 Net Sales at Rs 580.39 crore, up 10.91% Y-o-Y
17.11.2025
IOL Chemicals Consolidated September 2025 Net Sales at Rs 567.53 crore, up 7.95% Y-o-Y
12.11.2025
IOL Chemicals Standalone September 2025 Net Sales at Rs 567.53 crore, up 7.95% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth